Literature DB >> 11832204

Cancer modeling in the modern era: progress and challenges.

Terry Van Dyke1, Tyler Jacks.   

Abstract

Genetically engineered mouse models have contributed extensively to the field of cancer research. The ability to manipulate the mouse germline affords numerous approaches toward understanding the complexities of this disease, possibly providing accurate preclinical models for therapeutic and diagnostic advances. This review highlights some of the current strategies for modeling cancer in the mouse, recent accomplishments, and key remaining challenges.

Entities:  

Mesh:

Year:  2002        PMID: 11832204     DOI: 10.1016/s0092-8674(02)00621-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  103 in total

Review 1.  Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors.

Authors:  Edna Cukierman; Daniel E Bassi
Journal:  Semin Cancer Biol       Date:  2010-05-07       Impact factor: 15.707

2.  Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models.

Authors:  Ekram Gad; Lauren Rastetter; Meredith Slota; Marlese Koehnlein; Piper M Treuting; Yushe Dang; Sasha Stanton; Mary L Disis
Journal:  Breast Cancer Res Treat       Date:  2014-11-14       Impact factor: 4.872

Review 3.  Integrating predictive biomarkers and classifiers into oncology clinical development programmes.

Authors:  Robert A Beckman; Jason Clark; Cong Chen
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

Review 4.  Preclinical development of molecular-targeted agents for cancer.

Authors:  Alberto Ocana; Atanasio Pandiella; Lillian L Siu; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2010-12-07       Impact factor: 66.675

5.  MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.

Authors:  Dean W Felsher
Journal:  Genes Cancer       Date:  2010-06

Review 6.  Preclinical mouse cancer models: a maze of opportunities and challenges.

Authors:  Chi-Ping Day; Glenn Merlino; Terry Van Dyke
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

7.  In vivo imaging of the mammary gland: the shape of things to come.

Authors:  Lewis A Chodosh; Robert D Cardiff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.

Authors:  David H Lum; Cindy Matsen; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2012-12

10.  Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.

Authors:  Timothy J Harris; Edward L Hipkiss; Scott Borzillary; Satoshi Wada; Joseph F Grosso; Hung-Rong Yen; Derese Getnet; Tullia C Bruno; Monica V Goldberg; Drew M Pardoll; Theodore L DeWeese; Charles G Drake
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.